Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000462937 | SCV000548692 | uncertain significance | Hereditary spastic paraplegia 28 | 2021-09-01 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with cysteine at codon 818 of the DDHD1 protein (p.Ser818Cys). The serine residue is moderately conserved and there is a moderate physicochemical difference between serine and cysteine. This variant is present in population databases (rs193261227, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with DDHD1-related conditions. ClinVar contains an entry for this variant (Variation ID: 408872). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mayo Clinic Laboratories, |
RCV001509453 | SCV001716184 | uncertain significance | not provided | 2022-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003168807 | SCV003865747 | uncertain significance | Inborn genetic diseases | 2023-02-15 | criteria provided, single submitter | clinical testing | The c.2432C>G (p.S811C) alteration is located in exon 11 (coding exon 11) of the DDHD1 gene. This alteration results from a C to G substitution at nucleotide position 2432, causing the serine (S) at amino acid position 811 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |